Symbol Name ID |
Ino80
INO80 complex subunit MGI:1915392 |
Allelic Composition Genetic Background |
Annotated Term | Reference |
2310065F04Riktm1.1Boet/2310065F04Riktm1.1Boet Ino80tm1.1Jland/Ino80tm1.1Jland Pax7tm1(cre)Mrc/Pax7+ involves: 129S1/Sv * 129X1/SvJ |
normal growth/size/body region phenotype | J:306156 |
normal muscle phenotype | J:306156 | |
2310065F04Riktm1.1Boet/2310065F04Riktm1.1Boet Ino80tm1.1Jland/Ino80tm1.1Jland Pax7tm1(cre/ERT2)Gaka/Pax7+ involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl |
normal muscle phenotype | J:306156 |
Ino80tm1.1Schg/Ino80+ Trp53tm1Tyj/Trp53tm1Tyj involves: 129S2/SvPas * C57BL/6J |
decreased lymphoma incidence | J:221224 |
increased sarcoma incidence | J:221224 | |
increased T cell derived lymphoma incidence | J:221224 | |
Ino80tm1.1Schg/Ino80tm1.1Schg Trp53tm1Tyj/Trp53tm1Tyj involves: 129S2/SvPas * C57BL/6J |
embryonic lethality, incomplete penetrance | J:221224 |
preweaning lethality, complete penetrance | J:221224 |
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/12/2024 MGI 6.24 |
|
|